India to export hydroxychloroquine on case-by-case basis

India lifts the partial ban on hydroxychloroquine, the antimalarial drug, recommended for COVID-19 patients. The Ministry of External Affairs and pharma industry will decide on such allocations depending on the humanitarian crisis.

New Delhi:The government has decided to lift a partial ban on hydroxychloroquine after US President Donald Trump requested Prime Minister Narendra Modi to export the drug to aid America's fight against the deadly COVID-19 disease.

India has decided to export anti-malarial drug hydroxychloroquine to several countries including those in the neighbourhood on a case-by-case basis in sync with its commitment to the international community to fight the coronavirus pandemic, officials said on Tuesday.

Official sources told news agencies that the government will clear the existing orders immediately on humanitarian grounds. The Centre, sources said, will not ban but restrict the export of hydroxychloroquine and paracetamol depending on the availability of stock after meeting domestic requirements.

The Ministry of External Affairs and pharma industry will decide on such allocations depending on the humanitarian crisis, sources said.

Read:Hydroxychloroquine and retinal toxicity associated with it

President Trump had called Prime Minister Modi, requesting him to supply the anti-malaria drug hydroxychloroquine that is being used to treat COVID-19 patients and as prophylactic by the frontline health care workers deployed in the fight against the coronavirus pandemic.

The Modi government had imposed a ban on export of the drug since the coronavirus outbreak hit India.

The US as of now has the highest number of the novel coronavirus cases in the world, with over 367,000 cases of infections and over 10,800 deaths. Relatively, India has managed to contain the pandemic with 136 deaths and over 4,700 cases of infections.

On Monday, the Donald Trump administration provided $2.9 million in aid to India to help fight against the novel coronavirus disease. India has received requests from several other countries including its immediate neighbours Sri Lanka and Nepal for supply of hydroxychloroquine.

(IANS)